PRVC.F Stock Overview
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
PreveCeutical Medical Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.019 |
| 52 Week High | CA$0.025 |
| 52 Week Low | CA$0.011 |
| Beta | 1.06 |
| 1 Month Change | 5.08% |
| 3 Month Change | -3.63% |
| 1 Year Change | -12.47% |
| 3 Year Change | -13.49% |
| 5 Year Change | -62.80% |
| Change since IPO | -84.35% |
Recent News & Updates
Recent updates
Shareholder Returns
| PRVC.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -2.1% | -1.5% | -3.2% |
| 1Y | -12.5% | 9.7% | 19.3% |
Return vs Industry: PRVC.F underperformed the US Pharmaceuticals industry which returned 9.7% over the past year.
Return vs Market: PRVC.F underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| PRVC.F volatility | |
|---|---|
| PRVC.F Average Weekly Movement | 24.8% |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PRVC.F's share price has been volatile over the past 3 months.
Volatility Over Time: PRVC.F's weekly volatility (25%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Stephen Van Deventer | www.preveceutical.com |
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products.
PreveCeutical Medical Inc. Fundamentals Summary
| PRVC.F fundamental statistics | |
|---|---|
| Market cap | US$7.79m |
| Earnings (TTM) | -US$376.38k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-20.7x
P/E RatioIs PRVC.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PRVC.F income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$517.52k |
| Earnings | -CA$517.52k |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00097 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -70.0% |
How did PRVC.F perform over the long term?
See historical performance and comparison